Company Aposense Ltd TEL AVIV STOCK EXCHANGE

Aposense Ltd. is an Israel-based clinical stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. Aposense Ltd. has developed a novel class of rationally designed small molecules, which selectively identify cells from the early stages of apoptosis, cross the membrane and accumulate within the cell. The small weight molecules have a versatile structure, making them amenable to attachment and delivery of various imaging or therapeutic moieties to the apoptotic cells. These molecules can serve as a platform for imaging apoptotic cells and tissues or for targeted delivery of an active drug. The Company's partnerships and collaborations include Teva Pharmaceuticals, IBA (Ion Beam Application) S.A and Sigma-Aldrich.